A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
Clinical trial NCT06218290 · COMPLETED
Trial details
- NCT number
- NCT06218290
- Sponsor
- Unicycive Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2024-05-29
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.